Pharmed Limited Unlisted Shares
Industry: Manufacturing | Sector: Pharma | Depository: NSDL, CDSL
₹ 5,168.00
Key Indicators
| Key Indicators | 2025 |
|---|---|
| Current Share Price | 5,168.00 |
| Face Value | Share | 2.00 |
| Book Value | Share | 834.50 |
| Price To Earning (PE) | 6.90 |
| Price | Sales | 1.10 |
| Price | Book | 1.50 |
| Outstanding Shares (Crores) | 0.43 |
| Market Cap (Rs. Crores) | 555.35 |
| Debt | Equity | 0.30 |
| Dividend | Share | 0.00 |
| Dividend % (On Current Market Price) | 0.0% |
| Return on Total Assets | 17.6% |
| Return on Equity | 22.1% |
| Return on Working Capital | 25.5% |
* Ratio is calculated based on latest financial & current share price.
About The Company
Pharmed Limited (PL) is engaged in the manufacturing and marketing of pharmaceutical products in orthopedic, gynecologic, general health, pediatric and gastroenterology segments. It offers products of health, joint, bone and tendon health, pain management, cardio-diabetic health; ear, nose, and throat health and many more. The company sells its products under the brands 'Supracal', 'Cartigen', 'Absolut' and 'Tendocare'. The company has its branch offices located in Bangalore, Mumbai, Delhi, and Kolkata. The company was incorporated in 1946 and has its registered office located in Maharashtra.
Pricing Trend
Financial Summary
Revenue Growth %
EBITDA Margin %
NET Margin %
Profit & Loss Summary
(All Amount in ₹ Crores)
| PROFIT & LOSS | 2025 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 528.6 | 436.0 | 359.6 | 286.3 | 319.9 | 273.4 | 233.0 |
| Expense | 417.2 | 389.1 | 302.0 | 234.4 | 286.3 | 249.2 | 214.1 |
| EBITDA | 111.4 | 46.9 | 57.6 | 51.9 | 33.6 | 24.1 | 18.9 |
| Other Cost | 5.3 | 3.6 | 2.6 | 2.3 | 2.2 | 2.4 | 2.3 |
| Profit Before Taxes | 106.2 | 43.2 | 55.0 | 49.6 | 31.4 | 21.7 | 16.6 |
| Tax Expense | 25.3 | 10.2 | 12.7 | 12.2 | 7.4 | 6.6 | 5.4 |
| Profit after Taxes | 80.8 | 33.0 | 42.3 | 37.4 | 24.0 | 15.1 | 11.2 |
| Other Income | Exp. | -1.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Income (Net Of Taxes) | 79.3 | 33.0 | 42.3 | 37.4 | 24.0 | 15.1 | 11.2 |
| Outstanding Share | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 |
| Earning per Share (Rs | Share) | 187.51 | 76.9 | 98.4 | 86.9 | 55.8 | 35.2 | 26.1 |
| Revenue Growth % | - | -17.5% | -17.5% | -20.4% | 11.7% | -14.5% | -14.8% |
| EBITDA Margin % | 21.1% | 10.8% | 16% | 18.1% | 10.5% | 8.8% | 8.1% |
| Net Margin % | 15% | 7.6% | 11.8% | 13.1% | 7.5% | 5.5% | 4.8% |
| Earning per Share Growth % | - | -59% | 28% | -11.7% | -35.8% | -36.9% | -25.9% |
Balance Sheet
(All Amount in ₹ Crores)
| Balance Sheet | 2025 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalent | 10.1 | 12.7 | 4.4 | 6.0 | 6.1 | 3.3 | 2.5 |
| Non Current Asset | 347.5 | 221.2 | 196.0 | 152.4 | 127.9 | 103.0 | 82.7 |
| Current Asset | 92.6 | 55.9 | 61.8 | 48.3 | 39.8 | 45.6 | 33.9 |
| Total Asset | 450.3 | 289.8 | 262.3 | 206.8 | 173.8 | 151.9 | 119.1 |
| Equity Share Capital | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| Reserves | 358.0 | 230.2 | 198.7 | 159.4 | 122.2 | 97.9 | 82.9 |
| Total Equity | 358.8 | 231.1 | 199.6 | 160.3 | 123.0 | 98.7 | 83.7 |
| Non Current Liability | 13.5 | 9.2 | 7.4 | 6.4 | 5.7 | 5.2 | 4.8 |
| Current Liability | 77.9 | 49.5 | 55.3 | 40.0 | 45.1 | 48.0 | 30.6 |
| Total Liabilities | 91.4 | 58.7 | 62.7 | 46.5 | 50.8 | 53.2 | 35.4 |
| Total Equity & Liability | 450.3 | 289.8 | 262.3 | 206.8 | 173.8 | 151.9 | 119.1 |
Cash Flow Summary
(All Amount in ₹ Crores)
| CASH FLOW SUMMARY | 2025 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Operating Activity | 66.3 | 29.1 | 39.8 | 21.2 | 22.8 | 21.3 | 13.1 |
| Investing Activity | -52.6 | -18.9 | -38.0 | -21.0 | -19.5 | -20.0 | -13.6 |
| Financing Activity | -4.9 | -1.9 | -3.3 | -0.4 | -0.5 | -0.5 | -0.4 |
| Net Cash Flow | 8.7 | 8.3 | -1.6 | -0.1 | 2.8 | 0.8 | -0.9 |
Share Holding
Registered Address
ISIN: INE0EEI01017
PAN: AAACP2191A
PHARMED HOUSE141 WALCHAND, Mumbai,MH-400001
Management
Suneet Aurora
chairman & managing director
Venkataramani Krishnamurthy
chief financial officer
Download Financial Result
Top Unlisted companies
About Pharmed Limited Unlisted Shares
Pharmed Limited is one of the fastest-growing pharmaceutical companies, established in 1946. Over seven decades, the company has helped millions of people improve their quality of life and carry forward its legacy of "Caring for India." Headquartered in India's Silicon Valley, Bangalore, Pharmed Limited has become a renowned company among the Indian medical fraternity and provides a wide range of innovative products.
Pharmed Ltd is a pha...
Frequently Asked Questions
How to buy unlisted shares of Pharmed Ltd?
How to Sell unlisted shares of Pharmed Ltd?
What is the lock-in period of Pharmed Ltd unlisted shares?
What is the minimum ticket size for investment in Pharmed Ltd unlisted shares?
Is it legal to buy unlisted shares of Pharmed Ltd in India?
Is Short-term capital gain tax applicable on Pharmed Ltd unlisted shares?
Is there any Long-term capital gain tax to be paid on Pharmed Ltd unlisted shares?
Applicability of Taxes on Pharmed Ltd unlisted shares once it is listed?
How to check the credit or transfers of Pharmed Ltd unlisted shares?
What is the documentation requirement for dealing in unlisted shares?
What are expected returns on unlisted shares of Pharmed Ltd shares?
Is it beneficial to invest in Pharmed Limited unlisted shares?
Does Pharmed's financial performance affect its unlisted share price?
Can I buy unlisted shares of Pharmed Limited online?
What are the estimated short-term capital gain taxes on Pharmed unlisted shares?
Can I invest in Pharmed IPO shares in the future?